阅读说明：本技术 优选用于儿科受试者的治疗过敏性哮喘和复发性喘鸣的益生菌菌株的混合物 (Mixture of probiotic strains for the treatment of allergic asthma and recurrent wheezing, preferably for pediatric subjects ) 是由 V·莫格纳 M·帕内 A·阿莫鲁索 于 2020-03-06 设计创作，主要内容包括：本发明涉及属于物种短双歧杆菌的分离的细菌菌株(B632)DSM 24706,其用于治疗呼吸道的病症或病况或疾病以及用于治疗哮喘和呼吸窘迫。此外,本发明还涉及包含所述分离的细菌菌株或者由其组成的混合物,该混合物用于治疗呼吸道的病症或病况或疾病以及用于治疗哮喘和呼吸窘迫。此外,本发明涉及包含所述混合物和可选地至少一种生理学和/或药学可接受的添加剂和/或技术赋形剂的组合物,该组合物用于治疗呼吸道的病症或病况或疾病以及用于治疗哮喘和呼吸窘迫。所述分离菌株、所述混合物和所述组合物被有效施用和应用于儿科受试者的治疗中。(The present invention relates to an isolated bacterial strain belonging to the species bifidobacterium breve (B632) DSM24706 for use in the treatment of disorders or conditions or diseases of the respiratory tract and in the treatment of asthma and respiratory distress. Furthermore, the invention relates to mixtures comprising or consisting of said isolated bacterial strains for use in the treatment of disorders or conditions or diseases of the respiratory tract and for the treatment of asthma and respiratory distress. Furthermore, the present invention relates to compositions comprising said mixture and optionally at least one physiologically and/or pharmaceutically acceptable additive and/or technical excipient for the treatment of disorders or conditions or diseases of the respiratory tract and for the treatment of asthma and respiratory distress. The isolated strain, the mixture and the composition are effective for administration and use in the treatment of a pediatric subject.)